share_log
Reuters ·  Jun 13 16:06
Kintara Therapeutics Inc - Received a Letter From Nasdaq Advising That Company Had Been Granted a 180-Day Extension to December 9
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment